Found "Public health policy": 1,100 results
Sort by
Sort by
Relevance
Cost-Utility Analysis of Acetylcholinesterase inhibitors in the Treatment of Mild to Moderate Alzheimer’s disease (in Thai language)
The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch
Multi-criteria decision analysis for setting priorities on HIV/AIDS intervention in Thailand. (2012)
Link by http://www.health-policy-systems.com/content/10/1/6/abstract
Advanced health biotechnologies in Thailand: redefining policy directions.
For full text, click here http://www.translational-medicine.com/content/pdf/1479-5876-11-1.pdf
Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand (2013)
Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
Waranya Rattanavipapong1, Tanunya Koopitakkajorn1, Naiyana Praditsitthikorn1,2,*, Surakameth Mahasirimongkol3 andYot Teerawattananon1
Summary
Purpose
There is strong evidence o
Using Financial Mechanisms to Develop a Quality and Outcomes Framework: Issues and Challenges
In the fiscal year of 2014, the National Health Security Office (NHSO) started to disburse its budget based on the Quality and Outcomes Framework (QOF). The QOF is a budget allocation mechanism that incentivizes hospitals to provide quality primary care and achieve results based on the defined indic
Cetuximab as an adjuvant therapy for metastatic colorectal cancer (mCRC): Does the high cost outweigh the benefit for saving patient’s life?
Cetuximab is provided for mCRC patients with positive KRAS wild type, and also head and neck cancer patients as indicated in the Indonesian National Drug Formulary. However, currently, it is also used for indications not specified in the National Drug Formulary.
Adding cetuximab to chemothera
Would a rotavirus vaccination program for children under 5 years be cost-effective for Bhutan?
In many countries, rotavirus vaccination is the most cost-effective way to prevent rotavirus diarrhea. With this in mind, the Essential Medicines and Technology Division (EMTD) in collaboration with Health Intervention Technology Assessment Program (HITAP), Mahidol Oxford Research Unit (MORU), and P
Early HTA: A Guide for Developing Pulmonary Tuberculosis Cost-Effective Tests Fitting the Healthcare Needs
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (MTB) and represents a significant global health concern. Infectious agents can be easily spread through respiratory droplets, and TB patients face a significant risk of mortality.
The traditional sputum-based TB
The Life Saving Drug Program: Australia’s pathway to high-cost drugs
Australia developed the Life-Saving Drugs Program (LSDP) in 1995 to complement the Pharmaceutical Benefits Scheme (PBS), expanding access to high-cost drugs for rare diseases (DRD). This program, funded and administered by the Department of Health and Aged Care, permitted sponsors (often pharmaceuti
10 / Page